GOETTINGEN, Germany & LEVERKUSEN, Germany--(BUSINESS WIRE)--Sartorius Stedim Biotech GmbH (Paris:DIM), Goettingen, and Bayer Technology Services GmbH (BTS), Leverkusen, both located in Germany, have just signed an exclusive cooperation agreement on the manufacture and worldwide marketing of UVivatec® products. With the technology developed by BTS, viruses are inactivated in biopharmaceuticals by UVC irradiation. Typical areas of use are virus inactivation of cell culture media, antibody solutions and solutions containing recombinant proteins as well as irradiation of vaccines and therapeutics produced from blood and plasma. Further areas of application, such as removal of mycoplasma from bioreactor media, are currently being assessed.
